Abstract
- Background
Dietary habits represent an essential, modifiable factor influencing the risk of modern-day metabolic disorders, including cardiovascular disease, type 2 diabetes mellitus, obesity, and neurodegenerative conditions such as Alzheimer's disease. The therapeutic capability of specific whole foods and their isolated bioactive components to prevent, halt, or reverse the pathogenic mechanisms underlying these chronic conditions has drawn intense scientific interest. Red raspberries (Rubus idaeus L.) are a distinctive berry fruit possessing a rich phytotherapeutic profile, dense micronutrient content, dietary fibers, and an abundance of bioactive polyphenols—most notably ellagitannins and anthocyanins, the latter of which impart their vibrant red coloration. While numerous in vitro and in vivo investigations have elucidated the molecular mechanisms by which anthocyanins, ellagitannins (via ellagic acid and gut-derived urolithin metabolites), and whole red raspberry extracts mitigate metabolically associated pathophysiologies, comprehensive evaluations of human clinical data remain emerging. This review synthesizes the available scientific literature assessing the health-promoting potential of red raspberries and their constituent phytochemicals in modulating the risk of metabolic diseases—all of which share critical underlying links in oxidative stress and chronic inflammation.
- Methods
A structured literature evaluation was performed across major scientific databases—including PubMed, Scopus, Web of Science, and Embase—focusing on peer-reviewed biochemical analyses, cellular and animal models, and human clinical trials evaluating the consumption of red raspberries or isolated raspberry polyphenols. Data extraction prioritized examining mechanistic pathways involving oxidative stress reduction, inflammatory cytokine modulation, vascular endothelial protection, glycemic regulation, and neuroprotective signaling in the context of cardiovascular disease, diabetes, obesity, and Alzheimer's disease.
- Results
The synthesized evidence demonstrates that red raspberries and their bioactive polyphenols exert multi-targeted physiological benefits across major chronic metabolic disease domains:
Cardiovascular & Metabolic Protection: Red raspberry consumption significantly improves lipid metabolism, enhances endothelial-dependent vasodilation, regulates blood pressure, and optimizes peripheral insulin sensitivity, largely mediated through ellagitannins and their bioactive urolithin metabolites.
Glycemic & Obesity Regulation: Bioactive constituents in red raspberries effectively inhibit carbohydrate-digesting enzymes, blunt postprandial glycemic excursions, and mitigate obesity-associated systemic inflammation and adipokine dysregulation.
Neuroprotection & Alzheimer's Mitigation: Raspberry polyphenols cross the blood-brain barrier to attenuate neuroinflammation, suppress oxidative cellular damage, and inhibit enzymes linked to cognitive decline, supporting long-term neuronal resilience.
Shared Mechanisms (Oxidative & Inflammatory Links): Across all evaluated conditions, red raspberries consistently target common pathophysiological pathways, significantly suppressing reactive oxygen species (ROS) production, reducing pro-inflammatory cytokines, and modulating critical intracellular signaling cascades (such as NF-$\kappa$B).
The reviewed literature confirms an exceptional safety profile with high dietary tolerability.
- Conclusions
The growing body of scientific research strongly supports a therapeutic and preventive role for red raspberries in reducing the risk of metabolically based chronic diseases. By targeting shared oxidative, inflammatory, and metabolic pathways, red raspberries emerge as a powerful functional food matrix for promoting long-term health and disease prevention.
https://pubmed.ncbi.nlm.nih.gov/26773014/